Ergonovine Maleate Inj 0.2mg/mL .2 mg Liquid is a Health Canada–registered veterinary drug (DIN 00116300) held by Hoechst Canada (1996) Inc., containing Ergonovine Maleate. Health Canada lists its status as Cancelled Post Market (status date 10 Sep 1996). Nexara Health has matched 76 registrations of Ergonovine Maleate across 2 other regulated markets.
Health Canada registration
| DIN | 00116300 |
|---|---|
| Brand name | Ergonovine Maleate Inj 0.2mg/mL |
| Active ingredient | Ergonovine Maleate |
| Strength | .2 mg |
| Dosage form | Liquid |
| Route | Intramuscular ; Intravenous |
| Company | Hoechst Canada (1996) Inc. |
| Status | Cancelled Post Market — 10 Sep 1996 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Ergonovine Maleate registered in other markets
76 registrations of the same molecule in 2 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Taiwan | "Ubip" Ergonovine Maleate S.c. Tablets | 聯亞藥業股份有限公司新竹廠 | 糖衣錠 | 已註銷 | TFDA | |
| Taiwan | Arconovina | Arco Ltd. | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Brgometrine Maleate Tablets "Tainan" | 天乾製藥有限公司 | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Ergo Tablets | 金馬化學製藥股份有限公司蘆竹廠 | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Ergo-M S.c. Tablets "C.h."(Ergometrine Maleate) | 正和製藥股份有限公司新營廠 | 糖衣錠 | Registered | TFDA | |
| Taiwan | Ergolate Tablets | 應元化學製藥股份有限公司 | 錠劑 | Registered | TFDA | |
| Taiwan | Ergomat Injection (Ergonovine Maleate) | 瑞士藥廠股份有限公司新市廠 | 注射劑 | Registered | TFDA | |
| Taiwan | Ergomat Tablets (Ergonovine Maleate) | 健喬信元醫藥生技股份有限公司健喬廠 | 錠劑 | Registered | TFDA | |
| United States | Ergonovine Maleate | Teva Czech Industries s.r.o | Powder | FDA NDC | ||
| United States | Ergonovine Maleate | TAPI Czech Industries s.r.o. | Powder | FDA NDC |
See every manufacturer of Ergonovine Maleate worldwide →
Marketed Canadian products with the same active ingredient
| DIN | Product | Company | Strength | Form |
|---|---|---|---|---|
| 02441241 | Ergonovine Maleate Injection USP | Hikma Canada Limited | 0.25 mg | Solution |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Ergonovine Maleate Inj 0.2mg/mL (DIN 00116300) marketed in Canada?
No. Health Canada lists DIN 00116300 as Cancelled Post Market as of 10 Sep 1996.
Who holds the Canadian licence for this product?
Hoechst Canada (1996) Inc. is the company of record in the Health Canada Drug Product Database.
Is Ergonovine Maleate registered outside Canada?
Yes — Nexara Health has matched 76 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00116300, status date 1996-09-10; national medicine registries: FDA NDC, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00116300, status date 1996-09-10; national medicine registries: FDA NDC, TFDA.
Health Canada Drug Product Database (DPD), DIN 00116300, status date 1996-09-10; national medicine registries: FDA NDC, TFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.